Literature DB >> 25164037

Evidence from the 'PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)' study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer?

Marianne Schmid1, Michael Rink, Miriam Traumann, Patrick J Bastian, Georg Bartsch, Jörg Ellinger, Marc-Oliver Grimm, Boris Hadaschik, Axel Haferkamp, Oliver W Hakenberg, Atiqullah Aziz, Florian Hartmann, Edwin Herrmann, Markus Hohenfellner, Günter Janetschek, Michael Gierth, Sasc ha Pahernik, Chris Protzel, Jan Roigas, Murat Gördük, Lukas Lusuardi, Matthias May, Quoc-Dien Trinh, Margit Fisch, Felix K H Chun.   

Abstract

PURPOSE: The aim of this study was to examine preoperative patients' characteristics associated with the urinary diversion (UD) type (continent vs. incontinent) after radical cystectomy (RC) and UD-associated postoperative complications. MATERIALS: In 2011, 679 bladder cancer patients underwent RC at 18 European tertiary care centers. Data were prospectively collected within the 'PROspective MulticEnTer RadIcal Cystectomy Series 2011' (PROMETRICS 2011). Logistic regression models assessed the impact of preoperative characteristics on UD type and evaluated diversion-related complication rates.
RESULTS: Of 570 eligible patients, 28.8, 2.6, 59.3, and 9.3% received orthotopic neobladders, continent cutaneous pouches, ileal conduits, and ureterocutaneostomies, respectively. In multivariable analyses, female sex (odds ratio [OR] 3.9; p = 0.002), American Society of Anesthesiologists score ≥3 (OR 2.3; p = 0.02), an age-adjusted Charlson Comorbidity Index ≥3 (OR 4.1; p < 0.001), and a positive biopsy of the prostatic urethra in the last transurethral resection of the bladder prior to RC (OR 4.9; p = 0.03) were independently associated with incontinent UD. There were no significant differences in 30- and/or 90-day complication rates between the UD types. Perioperative transfusion rates and 90-day mortality were significantly associated with incontinent UD (p < 0.001, respectively). Limitations included the small sample size and a certain level of heterogeneity in the application of clinical pathways between the different participating centers.
CONCLUSIONS: Within this prospective contemporary cohort of European RC patients treated at tertiary care centers, the majority of patients received an incontinent UD. Female sex and pre-existing comorbidities were associated with receiving an incontinent UD. The risk of overall complications did not vary according to UD type.

Entities:  

Mesh:

Year:  2014        PMID: 25164037     DOI: 10.1245/s10434-014-4029-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  14 in total

1.  Factors influencing intraoperative conversion from planned orthotopic to non-orthotopic urinary diversion during radical cystectomy.

Authors:  Saum Ghodoussipour; Nariman Ahmadi; Natalie Hartman; Giovanni Cacciamani; Gus Miranda; Jie Cai; Anne Schuckman; Hooman Djaladat; Inderbir Gill; Siamak Daneshmand; Mihir Desai
Journal:  World J Urol       Date:  2018-12-05       Impact factor: 4.226

2.  Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta.

Authors:  Atiqullah Aziz; Michael Gierth; Michael Rink; Marianne Schmid; Felix K Chun; Roland Dahlem; Florian Roghmann; Rein-Jüri Palisaar; Joachim Noldus; Jörg Ellinger; Stefan C Müller; Armin Pycha; Thomas Martini; Christian Bolenz; Rudolf Moritz; Edwin Herrmann; Bastian Keck; Bernd Wullich; Roman Mayr; Hans-Martin Fritsche; Maximilian Burger; Patrick J Bastian; Christian Seitz; Sabine Brookman-May; Evanguelos Xylinas; Shahrokh F Shariat; Margit Fisch; Matthias May
Journal:  World J Urol       Date:  2015-05-07       Impact factor: 4.226

3.  Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan.

Authors:  Megumi Hirobe; Toshiaki Tanaka; Tetsuya Shindo; Koji Ichihara; Hiroshi Hotta; Atsushi Takahashi; Ryuichi Kato; Masahiro Yanase; Masanori Matsukawa; Naoki Itoh; Yasuharu Kunishima; Keisuke Taguchi; Hiroki Horita; Naoya Masumori
Journal:  Int J Clin Oncol       Date:  2018-02-13       Impact factor: 3.402

Review 4.  [Enhanced recovery after surgery-a concept, also in pediatrics].

Authors:  B Haid; L Lusuardi; J Oswald
Journal:  Urologe A       Date:  2020-03       Impact factor: 0.639

5.  [Continent urinary diversion following anterior exenteration].

Authors:  R Stein; M G Kamal; P Rubenwolf; A Großmann; C Thomas; J W Thüroff
Journal:  Urologe A       Date:  2015-03       Impact factor: 0.639

6.  Patient and disease-specific factors and their influence on urinary reconstruction choice at a referral center.

Authors:  Adam M Luchey; Gautum Agarwal; Patrick N Espiritu; Jorge L Lockhart; Julio M Pow-Sang; Philippe E Spiess; Wade J Sexton; Michael A Poch
Journal:  World J Urol       Date:  2015-03-15       Impact factor: 4.226

7.  Age, American Society of Anesthesiologists physical status classification and Charlson score are independent predictors of 90-day mortality after radical cystectomy.

Authors:  Vladimir Novotny; Michael Froehner; Rainer Koch; Stefan Zastrow; Ulrike Heberling; Steffen Leike; Matthias Hübler; Manfred P Wirth
Journal:  World J Urol       Date:  2015-12-11       Impact factor: 4.226

8.  [Urinary diversion with continent umbilical stoma: Which techniques are suitable for which patients?].

Authors:  T Kälble
Journal:  Urologe A       Date:  2015-09       Impact factor: 0.639

Review 9.  Female with bladder cancer: what and why is there a difference?

Authors:  Phillip Marks; Armin Soave; Shahrokh F Shariat; Harun Fajkovic; Margit Fisch; Michael Rink
Journal:  Transl Androl Urol       Date:  2016-10

10.  Comparison of postoperative complications of ileal conduits versus orthotopic neobladders.

Authors:  Liesbeth Demaegd; Maarten Albersen; Tim Muilwijk; Uros Milenkovic; Lisa Moris; Wouter Everaerts; Hendrik Van Poppel; Frank Van der Aa; Steven Joniau; Murat Akand
Journal:  Transl Androl Urol       Date:  2020-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.